Next Article in Journal
Thyroid Cancer Persistence in Patients with Unreliable Thyroglobulin Measurement: Circulating microRNA as Candidate Alternative Biomarkers
Next Article in Special Issue
Role of PARP Inhibitors in Cancer Immunotherapy: Potential Friends to Immune Activating Molecules and Foes to Immune Checkpoints
Previous Article in Journal
Chemosensitivity of 3D Pancreatic Cancer Organoids Is Not Affected by Transformation to 2D Culture or Switch to Physiological Culture Medium
Previous Article in Special Issue
Using Patient-Derived Xenograft (PDX) Models as a ‘Black Box’ to Identify More Applicable Patients for ADP-Ribose Polymerase Inhibitor (PARPi) Treatment in Ovarian Cancer: Searching for Novel Molecular and Clinical Biomarkers and Performing a Prospective Preclinical Trial
 
 
Review

Article Versions Notes

Cancers 2022, 14(22), 5619; https://doi.org/10.3390/cancers14225619
Action Date Notes Link
article xml file uploaded 16 November 2022 07:25 CET Original file -
article xml uploaded. 16 November 2022 07:25 CET Update -
article pdf uploaded. 16 November 2022 07:25 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5619/pdf-vor
article html file updated 16 November 2022 07:26 CET Original file -
article xml file uploaded 17 November 2022 02:40 CET Update -
article xml uploaded. 17 November 2022 02:40 CET Update https://www.mdpi.com/2072-6694/14/22/5619/xml
article pdf uploaded. 17 November 2022 02:40 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5619/pdf
article html file updated 17 November 2022 02:41 CET Update -
article html file updated 28 February 2023 23:13 CET Update -
article html file updated 3 March 2023 20:20 CET Update https://www.mdpi.com/2072-6694/14/22/5619/html
Back to TopTop